
False

About Philip J. Rosenfeld
Philip J. Rosenfeld
Professor of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
Rosenfeld, a retina specialist with a particular interest in the treatment and study of macular degeneration, has been a principal investigator of many of the pivotal clinical trials of anti-VEGF agents (and photodynamic therapy) for the treatment of retinal disease. Of his research into the ophthalmic application of bevacizumab, a nominator said, “Rosenfeld is the pioneer in its use. Now the most commonly used anti-VEGF in the world, its low cost and benefits have provided vision-saving therapy to millions.” He has received the AAO’s Senior Achievement and Secretariat Awards, the Macula Society’s Richard and Hinda Rosenthal Foundation Award, the Heed Award, the ASRS’ Founders Award and the J. Donald Gass Award from the Retina Society amongst many.
Explore More in Ophthalmology
Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
Newsletters
Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

False
False
False
Disclaimer
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: